Comparison of Atezolizumab/Bevacizumab Versus Durvalumab/Tremelimumab (STRIDE) Protocols in Locally Advanced or Metastatic Hepatocellular Carcinoma Among Patients in Sohag
ACTIVE_NOT_RECRUITING
Status
Conditions
- Locally Advanced or Metastatic Hepatoceullar Carcinoma
Sponsor
Sohag Oncology Center